 |
|
|
|
| ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
| ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
|
|
 |
|
|
In March 2004, the FDA asked Zyprexa (olanzapine) manufacturer Eli Lilly to issue a warning describing the increased risk of hyperglycemia and diabetes in patients taking this medication. Zyprexa, an atypical antipsychotic, is used to treat individuals with schizophrenia and bipolar disorder. One year after the FDA recommendation, in a June 2005 settlement, Eli Lilly agreed to pay $700 million to settle lawsuits against the company. Claimants stated that the company did not warn patients that Zyprexa is associated with a heightened risk of diabetes. In January 2007, the company announced further settlements not to exceed $500 million.
The FDA had approved Zyprexa in 1996. The new antipsychotic represented an opportunity for patients to effectively manage their diseases with fewer side effects. But many patients taking the drug became affected by hyperglycemia and diabetes, side effects not clearly displayed on the drug label by the drug maker. If you suffered any problems resulting from the use of using Zyprexa, please obtain a Free Consultation by submitting our online form, or by calling 1-800-543-9859.
Here are some other perscription drugs that have recently been recalled or have been linked to illnesses in users:
|
|
 |
|
|
|
|
|
| __________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
Don’t Hesitate to Contact Robert Peirce & Associates, P.C.
For a Free and Confidential Consultation
Robert Peirce & Associates, P.C.
2500 Gulf Tower, 707 Grant Street, Pittsburgh, PA 15219
P: 1-800-543-9859 F: 412-281-4229 |
| |
| Potential clients: Please be advised that submitting the "free consultation" form through our online system does not commit you to hiring our firm, and does not mean that you have retained an attorney for your potential case. The inquiry form will be reviewed by an attorney, and someone from Robert Peirce & Associates, P.C. will contact you to discuss the facts of your potential case. No attorney-client relationship is formed until a fee agreement is signed. We cannot guarantee the security of this site, and are not responsible for storing sensitive information. |
|
|
